SOLO2/ENGOT-Ov21: Maintenance Olaparib in Platinum-Sensitive Relapsed Ovarian Cancer (Final OS Analysis) Last updated on Jun 8, 2026 Previous AURELIA: Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer Next AtTEnd: Atezolizumab plus Chemotherapy for Advanced or Recurrent Endometrial Cancer
